P-glycoprotein/BCRP inhibitors (China Pharmaceutical University)

N/A

Report date: 2025/03/20 09:22:26
NME

Base Information

Drug NameP-glycoprotein/BCRP inhibitors (China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitorsBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2P-glycoprotein 1
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A